Remote Patient Monitoring Market to Reach $8.5 Billion by 2031, Growing at 16.3% CAGR
Remote Patient Monitoring Market demand and Growth
Remote patient monitoring leverages digital technologies to collect and transmit medical data such as vital signs, chronic disease status, and patient health records from the comfort of a patient’s home to healthcare providers. This enables early diagnosis, reduced hospital visits, and significant cost savings, making RPM one of the fastest-growing healthcare segments worldwide.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/1727
Key Growth Drivers
Rising Geriatric Population: According to the UN’s World Population Ageing 2020, the number of people aged 65+ is expected to double from 703 million in 2020 to 1.5 billion by 2050. This age group is more vulnerable to chronic conditions, boosting RPM adoption.
Lifestyle Disorders: Increasing prevalence of diabetes, COPD, hypertension, and cardiovascular diseases fuels demand for continuous monitoring devices.
Technological Advances: Innovations in mobile cardiac telemetry, wireless EEG recorders, and AI-driven RPM platforms are improving usability and expanding adoption across all age groups.
Cost Efficiency: According to the Centers for Medicare & Medicaid Services (CMS), RPM has reduced hospital readmissions by 76%, achieved 89% patient satisfaction, and saved over $370 million annually in medical costs.
Market Segmentation Insights
By Condition: The congestive heart failure (CHF) segment led in 2021 with revenues of $916.7 million, driven by the rising global heart disease burden.
By Component: Devices accounted for the largest share, generating $1.45 billion in 2021, reflecting growing demand for portable, home-based monitoring equipment.
By Region: North America dominated the market with $746.4 million in 2021, supported by advanced reimbursement systems, high chronic disease prevalence, and strong digital healthcare infrastructure. Meanwhile, Asia-Pacific is expected to record the fastest growth due to rising healthcare investments and increasing awareness of telehealth solutions.
COVID-19 Impact
The COVID-19 pandemic significantly accelerated RPM adoption. With hospital beds scarce and social distancing measures in place, healthcare providers turned to remote monitoring to ensure continuity of care. This shift not only highlighted RPM’s value but also embedded it into mainstream healthcare delivery models.
Competitive Landscape
Key players shaping the market include:
Abbott Laboratories
Biotronik SE & Co. KG
Boston Scientific Inc.
Datos Health
General Electric Healthcare
Honeywell International
Johnson & Johnson
Koninklijke Philips N.V.
Medtronic
Nihon Kohden Corporation
These companies are focusing on strategic collaborations, product innovations, and AI integration to enhance patient monitoring solutions and expand their global footprint.
Outlook
With rising healthcare costs, aging populations, and growing reliance on telehealth, remote patient monitoring is set to become a cornerstone of modern healthcare delivery. Advancements in connectivity, cloud-based solutions, and AI-driven analytics will further strengthen its role in preventive, personalized, and patient-centric care.
Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/1727
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
